Stocks and Investing
by (remove) : Mani Foroohar
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Mani Foroohar
RSSJSONXMLCSV
Mon, July 22, 2024
Mon, June 24, 2024
Fri, December 22, 2023
Tue, December 19, 2023
Thu, November 30, 2023
Fri, May 12, 2023
Wed, April 26, 2023
Thu, April 13, 2023
Wed, April 12, 2023
Mon, January 23, 2023
Fri, January 6, 2023
Wed, December 14, 2022
Tue, November 29, 2022
Mon, November 14, 2022
Thu, November 10, 2022
Mon, November 7, 2022
Thu, August 18, 2022
Thu, August 11, 2022
Thu, July 28, 2022
Tue, July 26, 2022
Wed, June 15, 2022
Fri, May 13, 2022
Wed, May 11, 2022
Fri, May 6, 2022

Mani Foroohar Initiated (BNTC) at Buy and Held Target at $13 on, Jul 22nd, 2024


Published on 2024-10-28 12:36:49 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of Leerink Partners, Initiated "Benitec Biopharma Inc." (BNTC) at Buy and Held Target at $13 on, Jul 22nd, 2024.

Mani has made no other calls on BNTC in the last 4 months.



There are 2 other peers that have a rating on BNTC. Out of the 2 peers that are also analyzing BNTC, 0 agree with Mani's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Mani


  • Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $30 on, Thursday, June 13th, 2024
  • Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Increased Target to $16 on, Monday, April 22nd, 2024
Contributing Sources